Engineered exosome therapeutics for neurodegenerative diseases
Life Sciences · 2024-11 · 356 · 123019
DOI: 10.1016/j.lfs.2024.123019 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Life Sciences, 2024-11. Verfasst von Biplob Saikia und 1 weiteren Autor:innen. Beteiligte Einrichtung: Manipal Institute of Regenerative Medicine, Manipal Academy of Higher Education, Manipal, India. Hauptthemen laut MEDLINE: Exosomes, Neurodegenerative Diseases, Mesenchymal Stem Cells. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Manipal Academy of Higher Education, Department of Biotechnology.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Manipal Institute of Regenerative Medicine, Manipal Academy of Higher Education, Manipal, India.
- Manipal Institute of Regenerative Medicine, Manipal Academy of Higher Education, Manipal, India. Electronic address: ds.anand@manipal.edu.
Förderung
- Manipal Academy of Higher Education
- Department of Biotechnology
Zitieren
APA
Saikia, B., & Dhanushkodi, A. (2024). Engineered exosome therapeutics for neurodegenerative diseases. Life Sciences, 356, 123019. https://doi.org/10.1016/j.lfs.2024.123019
Vancouver
Saikia B, Dhanushkodi A. Engineered exosome therapeutics for neurodegenerative diseases. Life Sciences. 2024;356:123019. doi:10.1016/j.lfs.2024.123019
BibTeX
@article{Saikia2024,
author = {Saikia, Biplob and Dhanushkodi, Anandh},
title = {Engineered exosome therapeutics for neurodegenerative diseases},
journal = {Life Sciences},
year = {2024},
volume = {356},
pages = {123019},
doi = {10.1016/j.lfs.2024.123019}
}
EUVIMED